HS 378
Alternative Names: HS-378Latest Information Update: 20 Oct 2023
At a glance
- Originator ChironWells
- Class Anti-inflammatories; Morphinans; Small molecules
- Mechanism of Action Calcineurin inhibitors; Immunosuppressants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Inflammation
Most Recent Events
- 12 Sep 2023 Early research in Inflammation in Austria (Parenteral) (ChironWells pipeline; September 2023)
- 12 Sep 2023 Early research in Inflammation in Austria (PO) (ChironWells pipeline; September 2023)
- 12 Sep 2023 Early research in Inflammation in Austria (Topical) (ChironWells pipeline; September 2023)